Literature DB >> 30360943

Extrahepatic autoimmunity in autoimmune liver disease.

Annarosa Floreani1, Sara De Martin2, Maria Francesca Secchi3, Nora Cazzagon3.   

Abstract

The most important autoimmune liver disease include: autoimmune hepatitis, primary biliary cholangitis and primary sclerosing cholangitis. In general, about one in three patients with an autoimmune liver disease have a concomitant extrahepatic autoimmune disease, which may include rheumatological, endocrinological, gastrointestinal, pulmonary or dermatological conditions. The pathogenesis of these conditions includes the production of both innate and adaptive immune responses targeting cholangiocytes as well as different extrahepatic tissues. In this sense, extrahepatic autoimmunity represent a continuous spectrum of autoimmunity involving liver and extrahepatic tissues. This review aims to focus the clinical and pathophysiological aspects of extrahepatic autoimmunity associated to autoimmune liver diseases.
Copyright © 2018 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autoimmune hepatitis; Autoimmunity; Primary biliary cholangitis; Primary sclerosing cholangitis

Mesh:

Year:  2018        PMID: 30360943     DOI: 10.1016/j.ejim.2018.10.014

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  6 in total

1.  Evaluation of Validity and Efficiency of Diagnostic Criteria in Autoimmune Hepatitis in Children.

Authors:  Mohammadhadi Imanieh; Nazanin Amin Farzaneh; Seyed Mohsen Dehghani; Maryam Gholami Shahrebabak; Samaneh Hamzelou Hosseinabadi
Journal:  Turk J Gastroenterol       Date:  2021-06       Impact factor: 1.852

2.  Autoimmune Hepatitis Associated With Cryoglobulinemic Vasculitis.

Authors:  Pedro Alves da Cruz Gouveia; Maria Teresa de Souza Portela Leal; Sylene Rampche
Journal:  ACG Case Rep J       Date:  2022-07-05

3.  Clinical significance of concomitant extrahepatic autoimmune disease in patients with autoimmune liver disease.

Authors:  Fatih Karakaya; Sura Oztekin; Yelda Ozturk; Cagdas Kalkan; Zeynep Melekoglu Ellik; Atilla Halil Elhan; Irfan Soykan; Ramazan Idilman
Journal:  Hepatol Forum       Date:  2021-01-08

Review 4.  The Nuclear Receptor PXR in Chronic Liver Disease.

Authors:  Katia Sayaf; Ilaria Zanotto; Francesco Paolo Russo; Daniela Gabbia; Sara De Martin
Journal:  Cells       Date:  2021-12-27       Impact factor: 6.600

5.  Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China.

Authors:  Zi-Xuan Shen; Dan-Dan Wu; Jie Xia; Xian-Bo Wang; Xin Zheng; Yan Huang; Bei-Ling Li; Zhong-Ji Meng; Yan-Hang Gao; Zhi-Ping Qian; Feng Liu; Xiao-Bo Lu; Jia Shang; Hua-Dong Yan; Yu-Bao Zheng; Wen-Yi Gu; Yan Zhang; Jian-Yi Wei; Wen-Ting Tan; Yi-Xin Hou; Qun Zhang; Yan Xiong; Cong-Cong Zou; Jun Chen; Ze-Bing Huang; Xiu-Hua Jiang; Sen Luo; Yuan-Yuan Chen; Na Gao; Chun-Yan Liu; Wei Yuan; Xue Mei; Jing Li; Tao Li; Xin-Yi Zhou; Guo-Hong Deng; Jin-Jun Chen; Xiong Ma; Hai Li
Journal:  World J Gastroenterol       Date:  2022-08-21       Impact factor: 5.374

6.  Characteristics and Inpatient Outcomes of Primary Biliary Cholangitis and Autoimmune Hepatitis Overlap Syndrome.

Authors:  Yi Jiang; Bing-Hong Xu; Brandon Rodgers; Nikolaos Pyrsopoulos
Journal:  J Clin Transl Hepatol       Date:  2021-03-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.